Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, December 6, 2024 
[ 12:02 PM ] - MSN
[ 12:01 PM ] - FXStreet
[ 12:01 PM ] - MSN
[ 10:31 AM ] - The Globe and Mail
[ 10:01 AM ] - Business Insider
[ 09:31 AM ] - MSN
[ 09:01 AM ] - The Globe and Mail
[ 08:01 AM ] - MSN
[ 07:31 AM ] - MSN
Billionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20%, According to Wall Street
- However, Englander's interest isn't limited to tech stocks. The billionaire recently bought an obesity drug stock that could soar nearly 20% over the next 12 months, according to Wall Street.
The article from The Motley Fool discusses billionaire investor Izzy Englander's recent investment in the obesity treatment sector. Englander, through his hedge fund Millennium Management, has been acquiring shares in companies like Eli Lilly and Novo Nordisk, which are at the forefront of developing and marketing weight-loss drugs such as Mounjaro and Wegovy. These drugs have shown significant promise in treating obesity, a condition affecting millions globally, and are expected to generate substantial revenue due to high demand. The article highlights the potential of these treatments to revolutionize obesity management, potentially leading to a multi-billion dollar market. Englander's investment reflects a broader trend among investors betting on the future of obesity treatments, driven by the drugs' efficacy and the growing prevalence of obesity-related health issues.
Read the Full The Motley Fool Article at:
[ https://www.fool.com/investing/2024/12/06/billionaire-izzy-englander-buying-obesity-stock/ ]
Read the Full The Motley Fool Article at:
[ https://www.fool.com/investing/2024/12/06/billionaire-izzy-englander-buying-obesity-stock/ ]
